Search This Blog

Sunday, November 26, 2023

Immunocore resumed at Overweight by JPMorgan

 Target $60

https://finviz.com/quote.ashx?t=IMCR&ty=c&ta=1&p=d

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.